Free Trial

Haleon (HLN) Competitors

Haleon logo
GBX 357.90 -1.10 (-0.31%)
As of 12:30 PM Eastern

HLN vs. SN, SGE, WHR, ANP, CLX, TPX, PNPL, LEG, ULVR, and BXP

Should you be buying Haleon stock or one of its competitors? The main competitors of Haleon include Smith & Nephew (SN), The Sage Group (SGE), Warehouse REIT (WHR), Anpario (ANP), Calnex Solutions (CLX), TPXimpact (TPX), Pineapple Power (PNPL), Legendary Investments (LEG), Unilever (ULVR), and Beximco Pharmaceuticals (BXP).

Haleon vs. Its Competitors

Smith & Nephew (LON:SN) and Haleon (LON:HLN) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, profitability, risk, dividends, media sentiment, institutional ownership and valuation.

Smith & Nephew has a beta of 0.62, suggesting that its share price is 38% less volatile than the S&P 500. Comparatively, Haleon has a beta of 0.19, suggesting that its share price is 81% less volatile than the S&P 500.

62.2% of Smith & Nephew shares are held by institutional investors. Comparatively, 43.9% of Haleon shares are held by institutional investors. 0.2% of Smith & Nephew shares are held by company insiders. Comparatively, 10.7% of Haleon shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Haleon has higher revenue and earnings than Smith & Nephew. Haleon is trading at a lower price-to-earnings ratio than Smith & Nephew, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Smith & Nephew£7.08B2.09£382.79M£27.7748.71
Haleon£11.07B2.92£1.07B£11.8930.10

In the previous week, Smith & Nephew had 5 more articles in the media than Haleon. MarketBeat recorded 9 mentions for Smith & Nephew and 4 mentions for Haleon. Smith & Nephew's average media sentiment score of 0.59 beat Haleon's score of -0.17 indicating that Smith & Nephew is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Smith & Nephew
2 Very Positive mention(s)
3 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Haleon
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Smith & Nephew presently has a consensus price target of GBX 1,379.33, indicating a potential upside of 1.95%. Haleon has a consensus price target of GBX 435, indicating a potential upside of 21.54%. Given Haleon's higher probable upside, analysts plainly believe Haleon is more favorable than Smith & Nephew.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Smith & Nephew
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
Haleon
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Haleon has a net margin of 9.66% compared to Smith & Nephew's net margin of 5.41%. Haleon's return on equity of 6.54% beat Smith & Nephew's return on equity.

Company Net Margins Return on Equity Return on Assets
Smith & Nephew5.41% 5.85% 4.51%
Haleon 9.66%6.54%4.45%

Smith & Nephew pays an annual dividend of GBX 29 per share and has a dividend yield of 2.1%. Haleon pays an annual dividend of GBX 6 per share and has a dividend yield of 1.7%. Smith & Nephew pays out 104.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Haleon pays out 50.5% of its earnings in the form of a dividend.

Summary

Smith & Nephew beats Haleon on 9 of the 17 factors compared between the two stocks.

Get Haleon News Delivered to You Automatically

Sign up to receive the latest news and ratings for HLN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HLN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HLN vs. The Competition

MetricHaleonDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£32.30B£2.23B£5.62B£3.09B
Dividend Yield0.02%2.92%4.61%5.04%
P/E Ratio30.104.1230.29169.94
Price / Sales2.92684.86463.41289,809.16
Price / Cash21.9510.3738.2127.94
Price / Book1.9711.118.825.22
Net Income£1.07B£20.70B£3.25B£5.89B
7 Day Performance1.39%2.98%4.05%-0.27%
1 Month Performance-2.62%5.87%4.32%0.38%
1 Year Performance-4.25%3.98%36.25%62.73%

Haleon Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HLN
Haleon
1.3628 of 5 stars
GBX 357.90
-0.3%
GBX 435
+21.5%
-4.2%£32.30B£11.07B30.1025,408
SN
Smith & Nephew
1.7971 of 5 stars
GBX 1,340.50
-0.3%
GBX 1,379.33
+2.9%
+16.4%£14.70B£7.08B48.2618,452High Trading Volume
SGE
The Sage Group
N/AGBX 1,113.24
-3.3%
GBX 3,500
+214.4%
+8.2%£11.02B£2.14B43.2711,326Dividend Increase
WHR
Warehouse REIT
N/AGBX 115.20
+0.3%
N/A+31.6%£488.01M£50.81M1.1261,000
ANP
Anpario
N/AGBX 384.60
-0.7%
GBX 435
+13.1%
+38.7%£65.62M£33.50M21.24109
CLX
Calnex Solutions
2.926 of 5 stars
GBX 47.25
-1.6%
GBX 115
+143.4%
-9.3%£41.99M£16.52M1,045.369,000News Coverage
Gap Up
TPX
TPXimpact
N/AGBX 19
-1.7%
N/A-56.8%£17.25M£84.64M-0.8412,000High Trading Volume
PNPL
Pineapple Power
N/AN/AN/AN/A£2.28MN/A-274.002High Trading Volume
LEG
Legendary Investments
N/AN/AN/AN/A£0.00N/A0.0019,900News Coverage
Gap Down
ULVR
Unilever
0.8084 of 5 stars
GBX 4,511.36
+0.1%
GBX 4,617.50
+2.4%
-3.3%£133.22B£70.72B20.40148,000High Trading Volume
BXP
Beximco Pharmaceuticals
N/AGBX 48.45
+2.0%
N/A+30.6%£33.03B£7.08T5.205,500Gap Up

Related Companies and Tools


This page (LON:HLN) was last updated on 8/14/2025 by MarketBeat.com Staff
From Our Partners